INSL3 in the muscolo-skeletal system
- 6 January 2019
- journal article
- research article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 487, 12-17
- https://doi.org/10.1016/j.mce.2018.12.021
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 SignalingPLOS ONE, 2013
- Muscle wasting in animal models of severe illnessInternational Journal of Experimental Pathology, 2012
- Activation of resorption in fatigue-loaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populationsBone, 2012
- Profiling Insulin Like Factor 3 (INSL3) Signaling in Human OsteoblastsPLOS ONE, 2011
- Regulation of circulating sclerostin levels by sex steroids in women and in menJournal of Bone and Mineral Research, 2010
- Association Between Testosterone and Estradiol and Age‐Related Decline in Physical Function in a Diverse Sample of MenJournal of the American Geriatrics Society, 2008
- Regulation of TORC1 by Rag GTPases in nutrient responseNature, 2008
- Mutations in the Insulin-Like Factor 3 Receptor Are Associated With OsteoporosisJournal of Bone and Mineral Research, 2008
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- The "Muscle-Bone Unit" in Children and AdolescentsCalcified Tissue International, 2002